ClinicalTrials.gov
public full text
Public Domain
Intranasal Insulin Treatment in Patients With Schizophrenia
This study is an 8-week, randomized, double-blind, placebo-controlled trial of intranasal insulin as an adjunctive therapy, with a 4-week follow-up, in 60 non-diabetic schizophrenia subjects to examine insulin's effect on psychopathology and cognition. In addition, the study will examine insulin's effects on weight, food intake, resting energy expenditure, and body composition.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Importance of Insulin Action in the Brain for the Immune System During Physical Activity#894005
- Aerobic Exercise for the Improvement of Cognition and Enhancement of Recovery in Post-acute Schizophrenia#912135
- Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart#1103282
- Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode#812134
- A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)#426723
Record · ID 1152188
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive